These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8585907)

  • 21. Novel cilia-dependent pathway activates rapid cyst growth in autosomal dominant polycystic kidney disease.
    Patankar JV
    Clin Genet; 2014 Mar; 85(3):230-2. PubMed ID: 24111686
    [No Abstract]   [Full Text] [Related]  

  • 22. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
    Elberg D; Jayaraman S; Turman MA; Elberg G
    Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autosomal dominant polycystic kidney].
    Jorge Adad S; Estevão Barbosa M; Fácio Luíz JM; Furlan Rodrigues MC; Iwamoto S
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(1):18-20. PubMed ID: 8762650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.
    Reddy BV; Chapman AB
    Pediatr Nephrol; 2017 Jan; 32(1):31-42. PubMed ID: 27034070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyst expansion and regression in a mouse model of polycystic kidney disease.
    Happé H; van der Wal AM; Salvatori DC; Leonhard WN; Breuning MH; de Heer E; Peters DJ
    Kidney Int; 2013 Jun; 83(6):1099-108. PubMed ID: 23466997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymmetric development of tumor-like cysts in a child with autosomal dominant polycystic kidney disease.
    Shiroyanagi Y; Suzuki M; Matsuno D; Mochizuki K; Kitagawa N; Tanaka M; Tanaka Y; Yamazaki Y
    J Pediatr Surg; 2008 Nov; 43(11):e21-3. PubMed ID: 18970915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal extracellular matrix and excessive growth of human adult polycystic kidney disease epithelia.
    Wilson PD; Hreniuk D; Gabow PA
    J Cell Physiol; 1992 Feb; 150(2):360-9. PubMed ID: 1734038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polycystic kidney disease: growth of cysts and recognition of phenotypes.
    Gardner KD
    Contrib Nephrol; 1995; 115():1-7. PubMed ID: 8585892
    [No Abstract]   [Full Text] [Related]  

  • 29. Focal overexpression of collagen IV characterizes the initiation of epithelial changes in polycystic kidney disease.
    Schäfer K; Bader M; Gretz N; Oberbäumer I; Bachmann S
    Exp Nephrol; 1994; 2(3):190-5. PubMed ID: 7922272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD).
    Lanoix J; D'Agati V; Szabolcs M; Trudel M
    Oncogene; 1996 Sep; 13(6):1153-60. PubMed ID: 8808689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of apolipoproteinA1 reduction in the polycystic kidney by proteomics analysis of the Mxi1-deficient mouse.
    Yoo KH; Kim YN; Lee MJ; Seong JK; Park JH
    Proteomics; 2009 Aug; 9(15):3824-32. PubMed ID: 19637234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of autosomal dominant polycystic kidney disease.
    Fick GM; Gabow PA
    Annu Rev Med; 1994; 45():23-9. PubMed ID: 8198379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pathogenesis of autosomal dominant polycystic kidney disease.
    Yoder BK; Mulroy S; Eustace H; Boucher C; Sandford R
    Expert Rev Mol Med; 2006 Jan; 8(2):1-22. PubMed ID: 16515728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of alpha-integrin subunits in fetal polycystic kidney diseases.
    Daïkha-Dahmane F; Narcy F; Dommergues M; Lacoste M; Beziau A; Gubler MC
    Pediatr Nephrol; 1997 Jun; 11(3):267-73. PubMed ID: 9203171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease.
    Xu Y; Li A; Wu G; Liang C
    Curr Gene Ther; 2017; 17(1):43-49. PubMed ID: 28494735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autosomal Dominant Polycystic Kidney Disease: A Path Forward.
    Rangan GK; Lopez-Vargas P; Nankivell BJ; Tchan M; Tong A; Tunnicliffe DJ; Savige J
    Semin Nephrol; 2015 Nov; 35(6):524-37. PubMed ID: 26718155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
    Harris PC
    Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Puzzling polycystin.
    Al-Awqati Q
    Mol Med; 1996 Nov; 2(6):663-4. PubMed ID: 8972481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.